NCT00937417: S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors |
|
|
| Withdrawn | 1 | 0 | NA | docetaxel, vandetanib, proteomic profiling, laboratory biomarker analysis, pharmacological study | Southwest Oncology Group, National Cancer Institute (NCI) | Breast Cancer, Head and Neck Cancer, Lung Cancer, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific | 09/09 | 09/09 | | |
